This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Cottrell, W. J. Articles by Oseroff, A. R. PubMed PubMed Citation Articles by Cottrell, W. J. Articles by Oseroff, A. R.

Irradiance-Dependent Photobleaching and Pain in -Aminolevulinic Acid-Photodynamic Therapy of Superficial Basal Cell Carcinomas

Authors' Affiliations: ¹ The Institute of Optics and ² Department of Imaging Sciences, University of Rochester, Rochester, New York and ³ Department of Dermatology, Roswell Park Cancer Institute, Buffalo, New York

Requests for reprints: Thomas H. Foster, Department of Imaging Sciences, University of Rochester, 601 Elmwood Avenue, Box 648, Rochester, NY. E-mail: Thomas.Foster{at}Rochester.edu or Allan R. Oseroff, Department of Dermatology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263. E-mail: allan.oseroff{at}roswellpark.org.

Purpose: In superficial basal cell carcinomas treated with photodynamic therapy with topical -aminolevulinic acid, we examined effects of light irradiance on photodynamic efficiency and pain. The rate of singlet-oxygen production depends on the product of irradiance and photosensitizer and oxygen concentrations. High irradiance and/or photosensitizer levels cause inefficient treatment from oxygen depletion in preclinical models.

Experimental Design: Self-sensitized photobleaching of protoporphyrin IX (PpIX) fluorescence was used as a surrogate metric for photodynamic dose. We developed instrumentation measuring fluorescence and reflectance from lesions and margins during treatment at 633 nm with various irradiances. When PpIX was 90% bleached, irradiance was increased to 150 mW/cm² until 200 J/cm² were delivered. Pain was monitored.

Results: In 33 superficial basal cell carcinomas in 26 patients, photobleaching efficiency decreased with increasing irradiance above 20 mW/cm², consistent with oxygen depletion. Fluences bleaching PpIX fluorescence 80% (D80) were 5.7 ± 1.6, 4.5 ± 0.3, 7.5 ± 0.8, 7.4 ± 0.3, 12.4 ± 0.3, and 28.7 ± 7.1 J/cm², respectively, at 10, 20, 40, 50, 60 and 150 mW/cm². At 20-150 mW/cm², D80 doses required 2.5-3.5 min; times for the total 200 J/cm² were 22.2-25.3 min. No significant pain occurred up to 50 mW/cm²; pain was not significant when irradiance then increased. Clinical responses were comparable to continuous 150 mW/cm² treatment.

Conclusions: Photodynamic therapy with topical -aminolevulinic acid using 40 mW/cm² at 633 nm is photodynamically efficient with minimum pain. Once PpIX is largely photobleached, higher irradiances allow efficient, rapid delivery of additional light. Optimal fluence at a single low irradiance is yet to be determined.